ArrowMark Colorado Holdings LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:36 pm Sale | 2025-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | ArrowMark Colorado Holdings LLC | 3,090,093 5.810% | -557,198 (-15.28%) | Filing |
| 2024-11-14 12:24 pm Purchase | 2024-09-30 | 13G | PMV PHARMACEUTICALS INC PMVP | ArrowMark Colorado Holdings LLC | 3,647,291 7.080% | 933,148 (+34.38%) | Filing |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | ArrowMark Colorado Holdings LLC | 2,714,143 5.310% | 2,714,143 (New Position) | Filing |